NEW YORK (GenomeWeb) – The European Organisation for Treatment of Cancer and 14M Genomics today announced a collaboration to use genomic profiling for enrollment into cancer clinical trials.

Under the terms of the agreement, 14M Genomics will analyze genomic variation of patients newly diagnosed with colorectal, thoracic, brain, and skin cancers for the EORTC Screening Patients for Efficient Clinical Trial Access (SPECTA) program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.